We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
Genscript Anti-Ustekinumab Antibody (9A5), mAb, Mouse
Genscript Anti-Ustekinumab Antibody (9A5), mAb, Mouse - GSCRPT (Additional S&H or Hazmat Fees May Apply)
List Price
$144.00
Your Price
$144.00
HOW MUCH YOU SAVE:
0.00 %
NETA PART: | GSCRPT-A02118-40 |
MFG.PART: | A02118-40 |
UNSPSC: | 12352203 |
Manufacturer: | GenScript USA Inc |
Overview
Specificity | This product is specific for Ustekinumab |
Host Species | Mouse |
Immunogen | Ustekinumab |
Conjugate | Unconjugated |
Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
|
Properties
Form | Lyophilized |
Storage Buffer | This product is lyophilized with PBS, pH 7.2, containing 0.02% sodium azide. |
Reconstitution | Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml. |
Storage Instructions | The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles. |
Purification | Protein A affinity column |
Isotype | Mouse IgG1,κ |
Clonality | Monoclonal |
Clone ID | 9A5 |
Note | GenScript can customize this product per customers request including product size, buffer components, etc. |
Background
Target Background | Ustekinumab with trade name Stelara, is an FDA-approved drug to Crohns disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis, targeting both interleukins (IL)-12 and IL-23. Ustekinumab is a fully human immunoglobulin G1 kappa mAb that binds to IL-12 and IL-23. Ustekinumab binds to the p40 subunit common to IL-12 and IL-23 and prevents their interaction with the IL-12 receptor β1 subunit of the IL-12 and IL-23 receptor complexes, thereby disrupting the proinflammatory pathway.Anti-Ustekinumab Antibody (9A5), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Ustekinumab. |
Synonyms | Mouse monoclonal to Ustekinumab/Stelara |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
SKU | GSCRPT-A02118-40 |
---|---|
Supplier Part Number | A02118-40 |
UM | EA |
UNSPSC | 12352203 |
Manufacturer | GenScript USA Inc |
ProductLine | GSCRPT |
Qty | 1 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 7 Business Days |
Hazardous | N |